{"id":"https://openalex.org/W7204077575","doi":"https://doi.org/10.3390/cimb48101012","title":"Myeloid-Adaptive Response to Atezolizumab (MARTA): A Two-Gene CXCL13\u2013CXCL8 Transcriptomic Biomarker Across Renal Cell and Urothelial Carcinoma","display_name":"Myeloid-Adaptive Response to Atezolizumab (MARTA): A Two-Gene CXCL13\u2013CXCL8 Transcriptomic Biomarker Across Renal Cell and Urothelial Carcinoma","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7204077575","doi":"https://doi.org/10.3390/cimb48101012","pmid":"https://pubmed.ncbi.nlm.nih.gov/42939550","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13703666"},"language":"en","primary_location":{"id":"doi:10.3390/cimb48101012","doi":"https://doi.org/10.3390/cimb48101012","is_oa":true,"landing_page_url":"https://doi.org/10.3390/cimb48101012","pdf_url":null,"source":{"id":"https://openalex.org/S62841813","display_name":"Current Issues in Molecular Biology","issn_l":"1467-3037","issn":["1467-3037","1467-3045"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311742","host_organization_name":"Caister Academic Press","host_organization_lineage":["https://openalex.org/P4310311742"],"host_organization_lineage_names":["Caister Academic Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Issues in Molecular Biology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3390/cimb48101012","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043785164","display_name":"Mario Uccello","orcid":"https://orcid.org/0000-0002-0741-1668","observed_orcids":["https://orcid.org/0000-0002-0741-1668"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mario Uccello","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0741-1668","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5043785164"],"corresponding_institution_ids":[],"apc_list":{"value":2200,"currency":"CHF","value_usd":2654},"apc_paid":{"value":2200,"currency":"CHF","value_usd":2654},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.57976487,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":"10","first_page":"1012","last_page":"1012"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.03539999946951866,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9710000157356262},{"id":"https://openalex.org/keywords/cxcl13","display_name":"CXCL13","score":0.7910000085830688},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":1.0},{"id":"https://openalex.org/keywords/transcriptomic-biomarkers","display_name":"transcriptomic biomarkers","score":0.9190000295639038},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-response","display_name":"immune checkpoint inhibitor response","score":0.6620000004768372},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.9570000171661377},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8600000143051147},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.9879999756813049},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8130000233650208},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9909999966621399},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8970000147819519},{"id":"https://openalex.org/keywords/imvigor210","display_name":"IMvigor210","score":1.0}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.9765999913215637},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7002999782562256},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6259999871253967},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.5562999844551086},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5410000085830688},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5307000279426575},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.5293999910354614},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5127000212669373},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.46630001068115234},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.4056999981403351},{"id":"https://openalex.org/C2781068499","wikidata":"https://www.wikidata.org/wiki/Q3242950","display_name":"Kidney cancer","level":3,"score":0.3785000145435333},{"id":"https://openalex.org/C78795084","wikidata":"https://www.wikidata.org/wiki/Q5113900","display_name":"Chromophobe cell","level":4,"score":0.36489999294281006},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3179999887943268},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.31209999322891235},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.30979999899864197},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.2881999909877777},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.28439998626708984},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.28299999237060547},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.2816999852657318},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.27219998836517334},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.25440001487731934},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.2522999942302704}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3390/cimb48101012","doi":"https://doi.org/10.3390/cimb48101012","is_oa":true,"landing_page_url":"https://doi.org/10.3390/cimb48101012","pdf_url":null,"source":{"id":"https://openalex.org/S62841813","display_name":"Current Issues in Molecular Biology","issn_l":"1467-3037","issn":["1467-3037","1467-3045"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311742","host_organization_name":"Caister Academic Press","host_organization_lineage":["https://openalex.org/P4310311742"],"host_organization_lineage_names":["Caister Academic Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Issues in Molecular Biology","raw_type":"journal-article"},{"id":"doi:10.20944/preprints202608.1642.v1","doi":"https://doi.org/10.20944/preprints202608.1642.v1","is_oa":true,"landing_page_url":"https://doi.org/10.20944/preprints202608.1642.v1","pdf_url":null,"source":{"id":"https://openalex.org/S6309402219","display_name":"Preprints.org","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:13703666","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13703666/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13703666/pdf/cimb-48-01012.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Curr Issues Mol Biol","raw_type":"Text"},{"id":"pmid:42939550","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42939550","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current issues in molecular biology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:05e7d7a7d1d845c7842bc480f072a807","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/05e7d7a7d1d845c7842bc480f072a807","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Current Issues in Molecular Biology, Vol 48, Iss 10, p 1012 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/cimb48101012","doi":"https://doi.org/10.3390/cimb48101012","is_oa":true,"landing_page_url":"https://doi.org/10.3390/cimb48101012","pdf_url":null,"source":{"id":"https://openalex.org/S62841813","display_name":"Current Issues in Molecular Biology","issn_l":"1467-3037","issn":["1467-3037","1467-3045"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311742","host_organization_name":"Caister Academic Press","host_organization_lineage":["https://openalex.org/P4310311742"],"host_organization_lineage_names":["Caister Academic Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Issues in Molecular Biology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204077575.pdf","grobid_xml":"https://content.openalex.org/works/W7204077575.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1857682357","https://openalex.org/W2099752220","https://openalex.org/W2114843025","https://openalex.org/W2130430382","https://openalex.org/W2132379894","https://openalex.org/W2149441684","https://openalex.org/W2289712604","https://openalex.org/W2559804019","https://openalex.org/W2655262992","https://openalex.org/W2785803176","https://openalex.org/W2805302875","https://openalex.org/W2807534769","https://openalex.org/W2897815318","https://openalex.org/W2904444972","https://openalex.org/W2924194495","https://openalex.org/W2945057866","https://openalex.org/W2987436342","https://openalex.org/W2994692693","https://openalex.org/W2998795792","https://openalex.org/W3000311037","https://openalex.org/W3020886383","https://openalex.org/W3021646013","https://openalex.org/W3096713247","https://openalex.org/W3115908825","https://openalex.org/W3118924526","https://openalex.org/W3128131226","https://openalex.org/W3136686797","https://openalex.org/W3177386775","https://openalex.org/W4214620261","https://openalex.org/W4296694188","https://openalex.org/W4310533676","https://openalex.org/W4313990830","https://openalex.org/W4380290766","https://openalex.org/W4386438154","https://openalex.org/W4392498919","https://openalex.org/W4398213922","https://openalex.org/W4399578568","https://openalex.org/W4400136170","https://openalex.org/W4401708261","https://openalex.org/W4401908548","https://openalex.org/W4402838988","https://openalex.org/W4404119826","https://openalex.org/W4411167305","https://openalex.org/W4413116749","https://openalex.org/W4415024933","https://openalex.org/W4416387355","https://openalex.org/W7133237215","https://openalex.org/W7162686297","https://openalex.org/W7165474485"],"related_works":["https://openalex.org/W4385322615","https://openalex.org/W4386170752","https://openalex.org/W4366158449","https://openalex.org/W3031433077","https://openalex.org/W3133688350","https://openalex.org/W3006754259","https://openalex.org/W4415597328","https://openalex.org/W3036281565","https://openalex.org/W2790303407","https://openalex.org/W2955456037"],"abstract_inverted_index":{"Transcriptomic":[0],"biomarkers":[1],"associated":[2,63,101,140],"with":[3,64,70,93,102,118,141],"response":[4,67],"to":[5,19],"immune-checkpoint":[6],"blockade":[7],"remain":[8],"incompletely":[9],"defined,":[10],"particularly":[11],"across":[12,48,128,187],"tumour":[13],"types.":[14],"We":[15],"developed":[16],"Myeloid\u2013Adaptive":[17],"Response":[18],"Atezolizumab":[20],"(MARTA),":[21],"a":[22,58,135],"two-gene":[23],"transcriptomic":[24],"score":[25,61,98,138],"integrating":[26],"CXCL13":[27],"and":[28,51,82,115,152,184],"CXCL8":[29],"expression.":[30],"Candidate-gene":[31],"selection":[32],"was":[33,46,62,99,139],"performed":[34],"in":[35,41,54,107,121],"81":[36],"patients":[37],"receiving":[38],"atezolizumab":[39,71,83],"monotherapy":[40],"IMmotion150,":[42,57],"after":[43,166],"which":[44],"MARTA":[45,60,97,137],"evaluated":[47],"treatment":[49],"groups":[50,110],"independently":[52],"assessed":[53],"IMvigor210.":[55],"In":[56,133],"higher":[59,65,96,136,142],"objective":[66],"rate":[68],"(ORR)":[69],"alone":[72],"(odds":[73],"ratio":[74,112],"[OR],":[75],"3.20;":[76],"95%":[77,88,149,159,171],"confidence":[78],"interval":[79],"[CI],":[80],"1.42\u20137.19)":[81],"plus":[84],"bevacizumab":[85],"(OR,":[86],"2.61;":[87],"CI,":[89,150,160,172],"1.43\u20134.76),":[90],"but":[91,181],"not":[92],"sunitinib.":[94],"A":[95],"also":[100],"longer":[103,153],"progression-free":[104],"survival":[105,155],"(PFS)":[106],"both":[108],"atezolizumab-containing":[109],"(hazard":[111],"[HR],":[113],"0.60":[114],"0.65,":[116],"respectively),":[117],"no":[119],"association":[120,126,164],"the":[122,125],"sunitinib":[123],"group;":[124],"differed":[127],"treatments":[129],"for":[130],"PFS":[131],"(P=0.01).":[132],"IMvigor210,":[134],"ORR":[143],"(OR":[144],"per":[145],"1-standard-deviation":[146],"increase,":[147],"1.38;":[148],"1.05\u20131.81)":[151],"overall":[154],"(OS)":[156],"(HR,":[157,169],"0.76;":[158],"0.67\u20130.86).":[161],"The":[162],"OS":[163],"remained":[165],"multivariate":[167],"adjustment":[168],"0.80;":[170],"0.68\u20130.95).":[173],"These":[174],"findings":[175],"support":[176],"further":[177],"evaluation":[178],"of":[179],"MARTA,":[180],"prospective":[182],"validation":[183],"analytical":[185],"reproducibility":[186],"platforms":[188],"are":[189],"required":[190],"before":[191],"clinical":[192],"application.":[193]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-08-25T00:00:00"}